Altertümer / Mk-2866 Raw Powder CAS 841205-47-8 a good way to build muscle
Schnelle Details:
FALL 841205-47-8
Produktname: Altertümer,Enobosarm
Alias: GTx-024,MK-2866
Molekularformel: C19H14F3N3O3
Molekulargewicht: 389.3279696
Reinheit: 99%
Aussehen: Weißes Puder
White Powder Muscle Building Steroide Epiandrosteron: White Powder Muscle Building Steroide Epiandrosteron
Beschreibung:
MK-2866 / Enobosarm / Ostarine is a nonsteroidal SARM / selective androgen receptor modulator, that has tissue-selective anabolic effects in muscle and bone, sparing other androgenic tissue related to hair growth in female and prostate effects in male. MK-2866 / Enobosarm / Ostarine is one of the most favorable of any bodybuilding SARMS for being the most anabolic.
You can not campare it to anabolic steroids. But in one aspect, you also see none of the side effects you would see with steroids. MK-2866 / Enobosarm / Ostarine was originally prescribed for the treatment and prevention of muscle wasting. Cancer induced muscle wasting begins early in the course of a patient’s malignant disease. when given to the patients, lean muscle mass was observed.
Anwendung:
Selective androgen receptor modulators may be used by athletes to assist in training and increase physical stamina and fitness, potentially producing effects similar to anabolic steroids.
For research.
Altertümer (MK-2866) is a SARM developed by GTx for the prevention and treatment of muscle wasting. It may eventually be a medical prescription for the prevention of cachexia, atrophy and sarcopenia as well as for Hormone or Replacement Therapy.
Als Forschungschemikalie, Ostarine belongs to a class of chemicals know as SARMS or selective androgen receptor modulators. SARMS create selective anabolic activity at certain androgen receptors. In comparison to and other anabolic steroids, the advantage of SARMS, is they do not have androgenic activity in non-skeletal muscle tissues. Ostarine is effective in maintaining and increasing lean body mass
Other SARMs
| Name |
CAS-NR. |
Verwendung |
| AICAR |
2627-69-2 |
acts by entering nucleoside pools, significantly increasing levels of adenosine
during periods of ATP breakdown |
| MK2866 |
841205-47-8 |
medical prescription for prevention of cachexia, atrophy, and sarcopenia and
for Hormone or Testoserone Replacement Therapy. |
| MK-677 |
15972-10-0 |
for the treatment of frailty in the elderly |
| LGD-4033 |
1165910-22-4 |
pharmacological profile similar to that of enobosarm, Altertümer,MK-2866 |
| GW1516 |
317318-70-0 |
For obesity, diabetes, dyslipidemia and cardiovascular disease |
| Andarine(S4) |
401900-40-0 |
partial agonist, intended mainly for treatment of benign prostatic hypertrophy |
| SR9009 |
1379686-30-2 |
under development at The Scripps Research Institute (TSRI),
increases the level of metabolic activity in skeletal muscles of mice |
| RAD140 |
1182367-47-0 |
New generation for gaining mass and cutting edges |
| YK11 |
431579-34-9 |
YK11: a SARM and myostatin inhibitor in one
|
| AC262356 |
870888-46-3 |
New SARMS |
| SR9011 |
1379686-29-9 |
New SARMS |
| S23 |
1010396-29-8 |
New SARMS |
| GW0724 |
317318-84-6 |
New SARMS |
Verkaufsleiter